• Users Online: 331
  • Home
  • Print this page
  • Email this page

  About Us

  About the Journal

Neural Regeneration Research (NRR) is a peer-reviewed open-accessed journal published with monthly. NRR aims to duly report the prospective, creative, and popular basic and clinical research in the international field of neuroregeneration. NRR focuses on rapidly publishing the articles pertaining to brain injury, spinal cord injury, peripheral nerve injury, neurodegenerative diseases, and neuroimaging, which reflect the latest progress in neuroregeneration research, and aims to highlight the unique scientific characteristics of each article.

The journal publishes report or interim summary supported by NIH and other National Funds, standards and survey on neuroscience industry, meta-analysis and academic discussion on innovative technologies, methods and development ; outstanding article will be granted for rapid publication.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Exlibris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet

The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science

Impact Factor® as reported in the 2016 Journal Citation Reports® (Thomson Reuters, 2017): 1.769

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

Advertisements

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

  Scope of the journal

The journal will cover technical and clinical studies related to health, ethical and social issues in field of Nerve Regeneration Nervous System Physiological Phenomena. Articles with clinical interest and implications will be given preference.

Neural Regeneration Research (NRR) aims to duly report the prospective, creative, and popular basic and clinical research in the international field of neuroregeneration. NRR focuses on rapidly publishing the articles pertaining to neural stem cells, nerve tissue engineering, gene therapy, neurodegenerative diseases, and neuroimaging, which reflect the latest progress in neuroregeneration research, and aims to highlight the unique scientific characteristics of each article. NRR pays great attention to the timeliness of publishing. All manuscripts accepted will be published 90–180 days from the date of submission.

  Areas of Interest

–Brain Injuries; Spinal Cord Injuries; Peripheral Nerve Injuries; Neural Degeneration; Neuroimaging.
–Treatment of CNS/PNS disorders including Stem Cells and Cell-Based therapy; Gene Therapy; Neuromodulation; Tissue Engineering; Biomaterials; Pharmacological treatment; Neural prostheses and other exciting topics in the field.
–Neuronal injury and regeneration from a cellular to molecular perspective, including Axonal regeneration, neuroplasticity, neural repair and replacement, neural circuit or network construction, neuromodulation or signaling repair, nerve transplantation, and neurosynaptogenesis.

  Tenets

NRR insists on high academic quality, controlled by international reviewers, academic editors and linguistics editors. NRR emphasizes prospective, creative and scientific studies that reflect the highest standards of neuroregeneration research, and it strives to ensure that the unique academic characteristics of each article are clearly presented.

    Medknow Publications   Top
Feedback
Subscribe
Editorial board
Subscribe this journal
Submit articles
Most popular articles
Join us as a reviewer
Most Cited Articles
Email alerts
Recommend this journal